Investing
Opening Bell Analyst Calls Briefing for Thursday, October 27, 2022
Published:
Last Updated:
This report was sent to Briefing.com subscribers earlier today.
> Copa Holdings (CPA) upgraded to Buy from Neutral at UBS; tgt raised to $120
> Ferrari (RACE) upgraded to Buy from Hold at HSBC Securities
> Huazhu Group (HTHT) upgraded to Buy from Outperform at Daiwa Securities; tgt lowered to $34
> Medpace (MEDP) upgraded to Neutral from Sell at UBS; tgt raised to $238
> Renasant (RNST) upgraded to Outperform from Mkt Perform at Raymond James; tgt $41
> ServiceNow (NOW) upgraded to Outperform from Market Perform at MoffettNathanson; tgt $549
> Teradyne (TER) upgraded to Buy from Hold at Craig Hallum; tgt $120
> Vertiv (VRT) upgraded to Outperform from Market Perform at Cowen; tgt raised to $20
> ATI Physical Therapy (ATIP) downgraded to Hold from Buy at Jefferies; tgt lowered to $1.15
> Cano Health (CANO) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $5
> Dassault Systemes (DASTY) downgraded to Underweight from Neutral at JP Morgan
> Eagle Bancorp Montana (EBMT) downgraded to Neutral from Buy at Janney
> FormFactor (FORM) downgraded to Hold from Buy at Stifel; tgt $30
> Meta Platforms (META) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $105
> Meta Platforms (META) downgraded to Market Perform from Outperform at Cowen; tgt lowered to $135
> Meta Platforms (META) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> Seagate Tech (STX) downgraded to Neutral from Buy at UBS; tgt lowered to $55
> Silicon Labs (SLAB) downgraded to Hold from Buy at Needham
> Taylor Morrison Home (TMHC) downgraded to Neutral from Buy at BTIG Research
> Thermo Fisher (TMO) downgraded to Hold from Buy at The Benchmark Company
> Thor Industries (THO) downgraded to Hold from Buy at The Benchmark Company
> Trinity Capital (TRIN) downgraded to Neutral from Buy at Compass Point; tgt lowered to $12.75
> V.F. Corp (VFC) downgraded to Underweight from Neutral at JP Morgan; tgt $29
> Arcellx (ACLX) initiated with a Buy at Needham; tgt $31
> IDEAYA Biosciences (IDYA) initiated with a Buy at Citigroup; tgt $26
> JD.com (JD) initiated with a Buy at CMB International; tgt $78.5
> Lithium Americas (LAC) assumed with a Buy at B. Riley Securities; tgt lowered to $41
> Livent (LTHM) assumed with a Neutral at B. Riley Securities; tgt raised to $32
> Mercury (MRCY) initiated with an Outperform at Raymond James; tgt $55
> Mobileye Global (MBLY) initiated with a Hold at Spin-Off Research; tgt $25
> Nouveau Monde Graphite (NMG) assumed with a Buy at B. Riley Securities; tgt lowered to $7
> Piedmont Lithium (PLL) assumed with a Buy at B. Riley Securities; tgt raised to $108
> Roivant Sciences (ROIV) initiated with an Overweight at JP Morgan; tgt $7
> 5E Advanced Materials (FEAM) initiated with a Buy at B. Riley Securities; tgt $20
Research calls posted earlier this morning are available here.
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.